Govt Job: For M.Pharm, M.Sc under SERB-CRG funded project

Established in 1955 by the visionary industrialist Mr. BM Birla, BIT Mesra was founded with a clear vision to offer its young minds a space, where their imagination could take wings and their ideas fruition.

For over 6 decades now, the institute has nurtured minds with a rich heritage of academic excellence, developing learning frameworks that have been well ahead of times.

Post : Junior Research Fellow (JRF)

Applications are invited for the post of Junior Research Fellow in following project funded under SERB-CRG (2022-2025)

Project title : Development of Novel Antileukemics Through the Structural and Functional Studies of Engineered and Chimeric Plant-Type Asparaginases File No.: CRG//2021/006543

Name of PI& Co-PI : Dr. K K Pradhan, Dr. V K Nigam & Dr. H R Singh

Eligibility : M.Tech./ M.S/ M.Pharm./ M.Sc. in Bioengineering / Biotechnology / Pharm. Biotechnology. NET / GATE / GPAT or other national level examination qualifiers will be preferred.

Desirable skills : Design of Protein expression & purification, Local engineering (circular permutation, linker modification, motifs exchange, randomization),QbD, chimera-genesis and Exposure in SDS-PAGE as well as XRD techniques.

Duration : Initially for a period of 01 year & may be extended for a additional 02 year upon satisfactory performance

Felloship Rs/-pm : 31,000/- + HRA as applicable (First 2 Years) 35,000/- + HRA as applicable (Third Year)

Date and time of Interview :26th April 2022 & at 9.15 AM

Venue : Department of Pharmaceutical Sciences& Technology, BIT-Mesra

• Interested candidates are required to bring all original Certificates and testimonials along with one set of duly attested photocopy on the interview date. No TA/DA will be provided for attending the Interview.

• Candidates may please forward their Bio-data in advance to Dr. Kishanta Kumar Pradhan (Principal Investigator of the Project) through e-mail (kkpradhan@bitmesra.ac.in)

• Candidates appearing for online/offline interview should covey in advance to the PI.

• Selected candidate are expected to enroll for Ph.D. program of the institute after fulfilling admission criteria and would be given preference.

Terms & Conditions :
1. No TA/DA will be paid for attending the interview.
2. The above position is purely contractual.
3. Canvassing in any form will disqualify the candidate.

Related Posts

  • Pharma
  • April 19, 2024
  • 33 views
US FDA Mandates Label Updates On CAR-T Cancer Therapies

Washington: The U.S. Food and Drug Administration said on Thursday cancer therapies that use CAR-T technology will require changes to the so-called “boxed warning” to highlight the serious risk of T-cell blood…

  • Pharma
  • April 19, 2024
  • 24 views
Karnataka Fails To Take Action Against 1,700 Fake Doctors

Bengaluru: A startling revelation has come to light nearly 17,00 fake doctors have been identified in the AYUSH department in Karnataka. Shockingly, despite these discoveries, no significant action has been taken…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

US FDA Mandates Label Updates On CAR-T Cancer Therapies

US FDA Mandates Label Updates On CAR-T Cancer Therapies

Karnataka Fails To Take Action Against 1,700 Fake Doctors

Karnataka Fails To Take Action Against 1,700 Fake Doctors

Chhattisgarh Pharmacy Council Issued Certificates For Hundreds Of Fake Pharmacists Without Verification

Chhattisgarh Pharmacy Council Issued Certificates For Hundreds Of Fake Pharmacists Without Verification

Gujarat FDCA Approved 133 New Drug Manufacturing Units In FY24

Gujarat FDCA Approved 133 New Drug Manufacturing Units In FY24

DCGI Informs SLAs Antibiotic Combo Meropenem 1 Mg & EDTA For Injection Has No Approval

DCGI Informs SLAs Antibiotic Combo Meropenem 1 Mg & EDTA For Injection Has No Approval

DCA Raids Two Illegal Pharmacies; Seizes Stocks Of Over 60 Types Of Drugs

DCA Raids Two Illegal Pharmacies; Seizes Stocks Of Over 60 Types Of Drugs